With increased utilization of PD1 inhibitors in young patients with relapsed cHL and improvements in survival in this population, we will likely observe a growing number of patients who will seek counseling regarding pregnancy. This evidence concerns the gene PDCD1 and classic Hodgkin lymphoma.